Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.
 
Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n=
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n=
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1040 703
Bimekizumab 34 0
Brodalumab 450 0
Certolizumab 152 0
Efalizumab 35 0
Etanercept 310 69
Golimumab 25 0
Guselkumab 1003 0
Infliximab 102 1
Ixekizumab 726 0
Risankizumab 666 0
Secukinumab 1595 0
Tildrakizumab 731 0
Ustekinumab 744 0
Apremilast 638 0
Ciclosporin 401 0
Fumaderm 2682 0
Skilarence 2596 0
Methotrexate 3866 0
Tofacitinib 2 0
other systemics 351 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n=
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n=
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers